Cancer-Cell-Derived GABA Promotes β-Catenin-Mediated Tumor Growth and Immunosuppression

The authors reported that cancer cells with aberrant expression of glutamate decarboxylase 1 rewired glutamine metabolism for the synthesis of γ-aminobutyric acid (GABA)—a prominent neurotransmitter—in non-nervous tissues.